BL, I too am staying put. I've had many OTC stocks that have run and I have made money but CYDY is a different picture in itself. CYDY has a product, Lironlimab and it's successful so it is totally a different story here.

IMO, I believe this is just the start of the party and I base this on the possible indications that Lironlimab can work successfully for so I am just watching for what happens next with TNBC & mTNBC then Nash. After Nash, then it's possible to take out my cost and let it ride on the profits but I can't make that decision until I see what's going on at that point.

I always base my investment decisions on the whole companies plans, successes and what they say about the future and only the clinicians can tell us how each of these potential indications are doing and that is where I make my decisions.

Hope that helps & GLTU always BL for I really enjoy your posts over the years

HCIT